Category: Boston ScientificSyndicate content

Stryker may bid for Smith & Nephew following 6-month no-bid period | The week in medtech M&A

November 26, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Will Stryker bid on Smith & Nephew this week?: J&J demands $7.2 billion from Boston Scientific as trial begins; Will Orange County's medtech scene lose its juice without Allergan?; BD-CareFusion deal passes US anti-trust waiting period; Sources: Stryker weighs bid for Smith & Nephew

Will Stryker bid on Smith & Nephew this week?

November 24, 2014 by Brad Perriello

DAPT funk: Study raises questions about Boston Scientific's Synergy stent

November 26, 2014 by Val Kennedy

Researchers for the massive DAPT study find that drug-eluting stents may be safer than bare-metal stents, calling into question the value of Boston Scientific's next-gen Synergy stent.

DAPT funk: Study raises questions about Boston Scientific's Synergy stent

Researchers for the massive Dual Anti-platelet Therapy Study found that patients receiving drug-eluting stents had a lower rate of stent thrombosis and other major cardiovascular events than those treated with bare-metal stents, undermining the common perception that bare-metal stents are safer.

Plaintiffs in Bard's pelvic mesh MDL want cases tried together

November 25, 2014 by Brad Perriello

The plaintiffs in 185 lawsuits filed against C.R. Bard over its Avaulta pelvic mesh as part of a multi-district litigation want their cases tried together.

Plaintiffs in Bard's pelvic mesh MDL want cases tried together

Boston Scientific backs Iowa Approach's atrial fibrillation device

November 24, 2014 by Brad Perriello

Iowa Approach says it landed an investment from Boston Scientific for the ablation device it's developing to treat atrial fibrillation.

Boston Scientific backs Iowa Approach's atrial fibrillation device

J&J wants judge to make BSX pay $7.B over J&J's jilting by Guidant Corp. | Medtech legal news for the week of November 24, 2014

November 24, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: J&J demands $7.2 billion from Boston Scientific as trial begins; Bard still on the hook for its share of $5m pelvic mesh verdict; Boston Scientific to pay $18.5m in pelvic mesh case; Justice Dept. recoups $6B in False Claims Act cases

J&J demands $7.2 billion from Boston Scientific as trial begins

November 20, 2014 by MassDevice

Pelvic mesh trial losses pressure Boston Scientific

November 24, 2014 by MassDevice

Back-to-back losses in pelvic mesh lawsuits could drive up the cost – and urgency – of settling thousands of other such cases for Boston Scientific, legal experts say.

Pelvic mesh trial losses pressure Boston Scientific

Justice Dept. recoups $6B in False Claims Act cases

November 21, 2014 by Brad Perriello

The U.S. Justice Dept. says it recouped nearly $6 billion from civil cases alleging fraud and false claims against the federal government, including $2.3 billion from healthcare cases.

Justice Dept. recoups $6B in False Claims Act cases

The U.S. Justice Dept. said it recouped a record $5.69 billion in settlements and judgments from False Claims Act cases during the fiscal year ended Sept. 30, including some $2.3 billion in recoveries from healthcare cases.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp